Oncopeptides Chief Financial Officer Holger Lembrer takes office today

/PRNewswire/ -- Oncopeptides AB (publ.) (NASDAQ Stockholm: ONCO), a biotech company focused on commercialization, research, and development of therapies for...

Related Keywords

Norway ,Iceland ,Liechtenstein ,Stockholm ,Sweden ,United Kingdom ,Lichtenstein ,Monica Shaw ,Holger Lembrer ,Rolf Gulliksen ,Leadership Team ,European Union ,Global Head Of Corporate Communications ,Nasdaq ,Chief Financial Officer ,Global Head ,Corporate Communications ,Peptide Drug Candidate ,Marketing Authorization ,Small Cap ,Chief Financial Officer Holger Lembrer ,Oncopeptides Ab ,